Juergen Fleck is Head of Global Clinical Operations at Actithera, where he leads the execution of the company’s global clinical development programs. He brings extensive experience in clinical operations and radioligand therapy, with a proven track record of advancing complex oncology programs from early development through late-stage clinical trials. Prior to joining Actithera, Juergen held senior clinical development and operations leadership roles within the pharmaceutical industry, helping to translate innovative science into successful clinical programs. His expertise in global trial execution and operational strategy supports Actithera as it advances its next-generation radioligand therapies toward patients.